October marks Breast Cancer Awareness Month, a time to reflect on the impact breast cancer has on millions of women worldwide and to reaffirm our commitment to supporting the cause. As a clinical research organisation involved in maternal and child health, Pharmalys understands the importance of addressing all aspects of women’s health. Breast cancer awareness is not just a medical issue; it’s a personal one for many of us, both as healthcare professionals and individuals.
Breast cancer is the most commonly diagnosed cancer among women globally. According to the World Health Organisation, an estimated 2.3 million women were diagnosed with breast cancer in 2022 alone, with approximately 670 000 deaths globally. While advances in research and early detection have significantly improved survival rates, there is still much work to be done, particularly in raising awareness about preventive measures, early screening, and access to treatment.
We believe in empowering women with knowledge and resources, particularly during Breast Cancer Awareness Month. Awareness is the first step towards prevention. Through early detection methods, such as regular mammograms and self-examinations, many lives can be saved. It is important for all women, regardless of age, to understand the risk factors associated with breast cancer. Family history, genetics, lifestyle choices, and environmental factors all play a role in determining risk levels.
Beyond our professional commitment to health research, Pharmalys cares deeply about the communities we serve. Our work in maternal and child health has given us insight into the specific health challenges women face, especially in low-resource settings. Breast cancer is no exception, affecting women from all walks of life, regardless of age, background, or status. This lack of discrimination makes it even more critical to address the inequalities in healthcare access, where timely diagnosis and treatment remain a significant challenge in many parts of Africa, as well as globally. This underscores the importance of campaigns like Breast Cancer Awareness Month, which aims to highlight these disparities and advocate for improved services.
At Pharmalys, we are committed to supporting the efforts of healthcare professionals and organisations that promote breast cancer research and awareness. We stand in solidarity with the millions of women affected by breast cancer and strive to do our part in fostering a supportive environment for prevention, treatment, and recovery. This October, we encourage everyone to take a moment to learn about breast cancer, share resources, and support those who may be battling the disease. Together, we can make a difference.
By working together, increasing awareness, and promoting early detection, we hope to contribute to a future where breast cancer is no longer a life-threatening disease. Whether through research, education, or advocacy, Pharmalys remains committed to advancing women’s health and supporting breast cancer awareness initiatives year-round.
Sources used:
https://www.who.int/news-room/fact-sheets/detail/breast-cancer
